Preventive Health

Bar chart of every Phase 2 and Phase 3 brenipatide trial by listed enrollment, showing four Phase 3 trials in alcohol use disorder and major depression above a block of Phase 2 trials that includes opioid use disorder and smoking relapse.
GLP-1, Preventive Health

Lilly Accelerates Its Brenipatide Trials: Betting Millions on the First GLP-1 for Alcohol and Depression

The brenipatide Phase 3 program is Lilly’s bet that it can reach an alcohol and depression label before anyone else, and it pulls a possible approval years closer. Key Points Lilly sent brenipatide, an experimental GIP/GLP-1 drug, straight from Phase 1 into Phase 3 for alcohol use disorder and major depression, skipping the mid-stage trial

Scroll to Top